A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists
暂无分享,去创建一个
Carlo Scolastico | Gianpaolo Bravi | Laura Belvisi | Aldo Salimbeni | Giovanna Catalano | Massimo Mabilia | G. Bravi | L. Belvisi | M. Mabilia | C. Scolastico | G. Catalano | A. Salimbeni
[1] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[2] G. Chang,et al. An internal-coordinate Monte Carlo method for searching conformational space , 1989 .
[3] M. Vallotton,et al. The renin-angiotensin system , 1987 .
[4] E G McMahon,et al. Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists. , 1993, Journal of medicinal chemistry.
[5] J. Reid,et al. Peptides and central neural regulation of the circulation. , 1987, Physiological reviews.
[6] Roberto Todeschini,et al. A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists , 1994, J. Comput. Aided Mol. Des..
[7] W C Hutton,et al. Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties. , 1991, Journal of medicinal chemistry.
[8] J. Ponder,et al. An efficient newton‐like method for molecular mechanics energy minimization of large molecules , 1987 .
[9] Dennis J. Underwood,et al. Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor , 1994, J. Comput. Aided Mol. Des..
[10] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[11] P. Timmermans,et al. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. , 1990, Journal of medicinal chemistry.
[12] G. Cruciani,et al. Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .
[13] W. C. Hutton,et al. Conformationally Restricted Polysubstituted Biphenyl Derivatives with Angiotensin II Receptor Antagonist Properties. , 1991 .
[14] Svante Wold,et al. D-Optimal Designs in QSAR , 1993 .
[15] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[16] William J. Greenlee,et al. Imidazo(4,5-b)pyridine-Based AT1/AT2 Angiotensin II Receptor Antagonists. , 1994 .
[17] J. Major,et al. New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives. , 1992, Journal of medicinal chemistry.
[18] W. Price,et al. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. , 1991, Journal of medicinal chemistry.
[19] Anna Vulpetti,et al. On the role of the molecular electrostatic potential in modelling the activity of non-peptide angiotensin II receptor antagonists , 1993 .
[20] J. Major,et al. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives. , 1992, Journal of medicinal chemistry.
[21] P. Kollman,et al. Atomic charges derived from semiempirical methods , 1990 .
[22] G. Bravi,et al. Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles. , 1994, Journal of medicinal chemistry.